A Court Ruling Against Merck May Also Hurt Pfizer
In a setback for Merck, a federal judge refused to dismiss a whistleblower lawsuit that accuses the drugmaker of distorting so-called nominal pricing in order to build a huge customer base for its Nuvaring contraception device and three contraceptive pills. The lawsuit, which was filed by two former employees, also claims the drugmaker offered kickbacks to physicians in exchange for prescribing a cancer medication.
At issue is an alleged scheme in which Organon – which Merck (MRK) inherited as part of its 2009 purchase of Schering-Plough – offered a steep discount to Planned Parenthood for its contraceptive pro...
Source: Pharmalot - February 26, 2013 Category: Pharma Commentators Authors: Ed Silverman Tags: Uncategorized Birth Control Pills Contraception Contraceptives Medicaid Merck Nuvaring Organon Pfizer Planned Parentood Schering Plough Wyeth Source Type: blogs
Pharmalot… Pharmalittle… Good Morning
Rise and shine. Another busy day is on the way. As usual, we are dashing about as we hustle the short people off to their schoolhouses and hunt for our to-do list. If only we could remember everything that must be done without prompting. Yes, there is a pill for that. Anyway, please join us in our daily coping ritual by grabbing a cup of stimulation. And as always, here are some tidbits to get you started. Hope your day is grand and keep in touch. One more thing: a happy valentine’s day to our favorite sweetie, Mrs. Pharmalot…
J&J Loses $63M Verdict In Motrin Case (Boston Globe)
Obama Medicare Rebate Plan...
Source: Pharmalot - February 14, 2013 Category: Pharma Commentators Authors: Ed Silverman Tags: Uncategorized Actavis Caronia Hospira Medicare Mylan Laboratories Obama Protonix Teva Laboratories Source Type: blogs
Pfizer's Pfourteenth Settlement - a Small Reminder of Continuing Impunity
Well, that did not take long. Less than a month after its last legal settlements were announced, Pfizer had to settle again. The Details of the Settlement This case, involving charges filed by the Texas Attorney General, was only reported locally, e.g., here in the Houston Business Journal:The state of Texas will receive more than $36 million from two civil Medicaid fraud settlements with Pfizer Inc and Endo Pharmaceuticals, Attorney General Greg Abbott said Friday. Both companies will pay $18.17 million to the state, plus attorney fees and relator shares. The federal government is also entitled to a sha...
Source: Health Care Renewal - January 11, 2013 Category: Health Medicine and Bioethics Commentators Tags: executive compensation deception boards of directors impunity Pfizer legal settlements governance Source Type: blogs
